Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05546723
Title LMY-920 for Treatment of Relapsed or Refractory Myeloma (LMY-920-002)
Acronym LMY-920-002
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Luminary Therapeutics
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.